If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Marco Pozzi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Pediatrics Medicine & Life Sciences
Drug-Related Side Effects and Adverse Reactions Medicine & Life Sciences
Rehabilitation Medicine & Life Sciences
Pharmacovigilance Medicine & Life Sciences
Databases Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Brain Injuries Medicine & Life Sciences
Vaccines Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2013 2019

  • 441 Citations
  • 13 h-Index
  • 64 Article
  • 3 Letter
  • 3 Review article
Methylphenidate
United States Food and Drug Administration
Attention Deficit Disorder with Hyperactivity
Drug-Related Side Effects and Adverse Reactions
Emotions
1 Citation (Scopus)
Lipid Metabolism
Antipsychotic Agents
Cholesterol
Obesity
HDL Lipoproteins
Food Analysis
Hyponatremia
Drug-Related Side Effects and Adverse Reactions
Antidepressive Agents
Databases

Bullous pemphigoid induced by dipeptidyl peptidase-4 (DPP-4) inhibitors: a pharmacovigilance-pharmacodynamic/pharmacokinetic assessment through an analysis of the vigibase®

Carnovale, C., Mazhar, F., Arzenton, E., Moretti, U., Pozzi, M., Mosini, G., Leoni, O., Scatigna, M., Clementi, E. & Radice, S., Nov 1 2019, In : Expert Opinion on Drug Safety. 18, 11, p. 1099-1108 10 p.

Research output: Contribution to journalArticle

Dipeptidyl-Peptidase IV Inhibitors
Pharmacovigilance
Bullous Pemphigoid
Pharmacokinetics
Dipeptidyl Peptidase 4